Elkimia Inc.

Elkimia Inc. is a Canadian company founded in 2004 with a primary focus on the research, development, and manufacturing of patented active ingredients used for sun protection. The company's mission expanded in 2011 to include the development of new Mycosporine-like Amino Acids (MAAs) mimics as UV-protectants, leading to breakthrough applications in industries such as cosmetics, textiles, and coatings. Elkimia's innovative discoveries extend to potentially developing therapeutic benefits through their mimics. The company operates as a dynamic team of chemists and formulators with close partnerships with various institutions in Canada and internationally. In August 2022, Elkimia Inc. secured a Venture Round investment from Anges Québec and AQC Capital. With a focus on eco-friendly flow chemistry, Elkimia's unique approach and robust partnerships position it as an exciting prospect in the Health Care and Manufacturing industries.